Multi-Probiotic 15 Billion can be an effective dietary supplement, and may also help ease chronic pain and depression. Each probiotic capsule contains over 15 billion beneficial organisms that improve immune and gastrointestinal health. Probiotics are dietary bacteria that live in the intestinal tract and they’ve been shown to benefit the immune system through intestinal regulation. Support your immune system with a regular regimen of Multi-Probiotic 15 Billion.
- Technical Specs
Multi-Probiotic15 Billion capsules may be a useful dietary supplement for those who wish to support their intestinal microflora with potent amounts of beneficial microorganisms.
Ingredients / Formula
Each Capsule Contains:
Multi-Strain Probiotic Blend 15 Billion CFU
- Lactobacillus acidophilus (DDS-1).4.3 Billion CFU
- Lactobacillus rhamnosus (Lr-32)4.3 Billion CFU
- Bifidobacterium lactis (HN019)1.9 Billion CFU
- Lactococcus lactis (Ll-23)1.0 Billion CFU
- Bifidobacterium longum (Bl-05)1.0 Billion CFU
- Bifidobacterium bifidum (Bb-02) 1.0 Billion CFU
- Lactobacillus gasserri (Lg-36)1.0 Billion CFU
- Streptococcus thermophilus (St-21) 0.5 Billion CFU
- Digestive and Prebiotic Blend 210 mg
- FOS (fructooligosaccharides) and Ulmus fulva (bark)
- Other Ingredients: Gelatin (capsule), cellulose, vegetable stearate and silica.
Adults take one capsule daily or as directed by a healthcare professional.
No adverse side effects have been reported.
Refrigerate after opening with lid tightly sealed. Keep out of reach of children.
- Extended Information
These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.
Rerksuppaphol S, Rerksuppaphol L. Lactobacillus acidophilus and Bifidobacterium bifidum stored at ambient temperature are effective in the treatment of acute diarrhoea. Ann Trop Paediatr. 2010;30(4):299-304.
Mondot S, Kang S, Furet JP, Aguirre de Carcer D, McSweeney C, Morrison M,Marteau P, Doré J, Leclerc M. Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis. 2010 Aug 18.
Hong KS, Kang HW, Im JP, Ji GE, Kim SG, Jung HC, Song IS, Kim JS. Effect of probiotics on symptoms in korean adults with irritable bowel syndrome. Gut Liver.2009 Jun;3(2):101-7. Epub 2009 Jun 30.
Sang LX, Chang B, Zhang WL, Wu XM, Li XH, Jiang M. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World J Gastroenterolgy. 2010 Apr 21;16(15):1908-15
Robert J Boyle, Roy M Robins-Browne and Mimi LK Tang. Probiotic use in clinical practice: what are the risks? American Journal of Clinical Nutrition, Vol. 83, No. 6, 1256-1264, June 2006
Verna EC, Lucak S. Use of probiotics in gastrointestinal disorders: what to recommend? Therapeutic Advances in Gastroenterology 2010 3: 307-319
Rhode CL. The Use of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea with Special Interest in Clostridium difficile-Associated Diarrhea. Nutr Clin Pract 2009 24: 33-40.
Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. Randomized placebo-controlled trial of lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol. 2010 Nov;45(11):1111-20.
Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999;69:1046S-1051S.
Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69:1052S-1057S.
De Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1-66.
Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998;80:S209-12.
H.Lee, K.M.Shahani. Inhibitory Effect of Lactobacillus Acidophilus on transformation of bile acids by human fecal microflora. Microbiologie-Aliments-Nutrition.1995;13;241-247.
Murthy M, Venkitanarayan K.S., Rangavajhyala N and K.M. Shahani. Delineation of beneficial characteristics of effective probiotics. J. Am. Nutr. Assoc, 2000 3(2), 38-43
Ahmed, M et al. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging. 2007 Jan-Feb;11(1):26-31.
Waller, Phillip et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults.Scand J Gastro, 2011; 46: 1057-64.